Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up platform study of macitentan + tadalafil in pulmonary arterial hypertension
CTR20242225Phase 3Active
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of macitentan + tadalafil in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Started Jul 2024; status: active.
02
Drugs
macitentan + tadalafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on CTR20242225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242225.